Skip to main content
. 2021 Feb 19;9(2):434. doi: 10.3390/microorganisms9020434

Figure 7.

Figure 7

Treatment of HSV-1 with embelin inhibits the penetration step. (a) Cell viability as measured by luminescence 48 hpi indicates that treatment of virions with embelin significantly increased cell viability. (b) The percent inhibition of penetration stage of HSV-1 infection when virions were treated with embelin at concentrations ranging from 20 µM to 56 µM is reported. The greatest percentage of inhibition resulted from treatment of virions with 54 µM embelin.